Life Sciences
Breakthrough study of hormone “crosstalk” in breast cancer
Research
EPFL
Scientists led by EPFL have successfully engrafted breast cancer cells on mice, allowing them to study in vivo the cross-talk between the estrogen and progesterone receptors that hampers hormone therapies. Their findings suggest that endocrine therapy may need to be personalized, and that abrogating progesterone receptor expression can be a therapeutic option.
Streamlining stem cells to treat macular degeneration
Research
EPFL
Scientists at EPFL and the Karolinska Institute have tested and confirmed a protocol for growing human embryonic stem cells into retina cells to treat eye diseases such as age-related macular degeneration.
An anti-cancer drug acts as an epigenetic memory aid, scientists find
Research
EPFL
EPFL scientists have discovered how an anti-cancer drug could be repurposed to improve memory. It does so by supporting the cell’s ability to read the very genes that are important for learning. The epigenetic mechanism of the drug is shown in mice.
NeuroMechFly: a digital twin of Drosophila
Research
EPFL
EPFL scientists have developed a digital model of the fruit fly, Drosophila melanogaster, which realistically simulates the movements of the animal. The twin is a big step towards reverse engineering the neuromechanical control of animal behavior, and developing bioinspired robots.
Targeting “anti-tumor” genes to provide better treatment for leukemia
Research
EPFL
EPFL scientists discuss the possibility of offering personalized treatment for chronic lymphocytic leukemia by regulating the expression of a gene known for its “anti-tumorous” properties.
From cell fat to cell fate
Research
EPFL
A cell’s production of fat molecules can be a key factor in determining what that cell will become, show scientists at EPFL.
Page 10 of 16